Ledger.Open graph →
SEC Form D · Amendment · filed February 11, 2014

Novira Therapeutics, Inc

Offering
$29.8M
Sold
$28.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Tim M. Shannon · Westport, CTDirectorGeorge M. Hartman · Doylestown, PAExecScott M. Rocklage · Menlo Park, CADirectorOsvaldo S. Flores · Doylestown, PAExec · DirectorAnthony M. Ford-Hutchinson · Doylestown, PADirectorDaniel E. Geffken · W. Concord, MEExecGregory E. Korbel · Doylestown, PAExecGianni Gromo · Menlo Park, CADirectorHoward S. Garfield · Addison, TXDirectorRobert T. Poynter · Addison, TXDirectorRon C. Foster · Fayetteville, ARExec · DirectorGreg C. Lee · Fayetteville, ARExecScott M. Rocklage · Menlo Park, CADirectorDaniel E. Geffken · W. Concord, MEExecGregory E. Korbel · Doylestown, PAExecGianni Gromo · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗